Periprocedural Myocardial Infarction, Emboli Protection, and Mechanical Thrombectomy Flashcards

1
Q

What is the major mechanism for periprocedural myocardial infarction (MI)?

A

Embolization of microscopic debris with subsequent platelet activation and inflammation leading to impairment in microvascular flow

This mechanism highlights the importance of preventing embolic events during procedures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is required for distal embolic protection devices to function effectively?

A

A distal landing zone in the saphenous vein graft (SVG)

Without a safe landing zone, effective placement of devices like filter wires is not possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

True or False: The Proxis proximal protection system is currently available in the United States.

A

False

The Proxis system was formerly an option but is no longer commercially available.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What was the significant finding of the randomized trial of a distal embolic protection (DEP) device during PCI of saphenous vein aortocoronary bypass grafts?

A

A significant reduction in the composite endpoint of death, MI, emergency bypass, or target lesion revascularization at 30 days

The reduction was mainly driven by lower rates of MI and the ‘no-reflow’ phenomenon.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What was the dosage of atorvastatin used in the ARMYDA trial, and what was its effect?

A

40 mg/day administered 7 days before elective coronary intervention reduced myocardial injury markers

This trial showed significant reductions in CK-MB, troponin I, and myoglobin levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fill in the blank: In the SAFER trial, the use of distal protection devices resulted in a ______% relative risk reduction in the primary endpoint.

A

42

The primary endpoint was a composite of death, MI, emergency bypass, or target lesion revascularization by 30 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What factors are believed to increase the risk of periprocedural myonecrosis?

A
  • Genetic predisposition
  • Aspirin and clopidogrel resistance
  • Increased arterial inflammation

These factors play a crucial role in the development of myonecrosis during procedures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the relationship between periprocedural MI and mortality according to the EPIC trial?

A

A direct relationship between the degree of CK elevation post-procedure and 3-year mortality

Higher CK levels post-procedure correlate with increased mortality rates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What did the TAPAS trial demonstrate regarding manual aspiration during primary PCI?

A

Manual aspiration was superior to conventional treatment for improving myocardial blush grade

However, it did not show a significant difference in ‘hard’ clinical outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What was the MACE rate with the use of current embolic protection devices (EPDs)?

A

7% to 12% depending upon the device

This rate varies among different studies examining the effectiveness of EPDs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or False: The association between periprocedural MI and PCI has been linked to increased stroke risk.

A

False

Numerous studies have established the association with mortality but not with stroke risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are independent predictors of periprocedural MI identified in a retrospective study?

A
  • Bifurcation lesions
  • Multivessel procedures
  • Overall lesion treated length

These factors contribute significantly to the risk of MI during procedures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the primary endpoint of the EMERALD trial?

A

ST-segment resolution measured 30 minutes after PCI

The trial aimed to compare the efficacy of balloon occlusion and aspiration distal microcirculatory systems against angioplasty without distal protection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What catheter is the smallest among the ones mentioned, and what is its tip diameter?

A

Pronto LP with a tip diameter of 1.34 mm

This catheter is compatible with 6-Fr guides.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the effect of nitroglycerin in microvascular arterioles?

A

Less effective than other options due to inability to metabolize effectively

Sodium nitroprusside is more effective because it acts directly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the significance of ST-segment resolution greater than 70%?

A

Indicates improvement in myocardial function

ST-segment resolution is a key indicator of myocardial recovery after ischemic events.

17
Q

What was the outcome of the REMEDIA study regarding thrombus aspiration prior to PCI?

A

Improvement in myocardial blush score and ST resolution compared to PCI alone

This suggests that thrombus aspiration may enhance the effectiveness of PCI.

18
Q

What did the AIMI trial evaluate and what were its findings?

A

Evaluated 480 patients and failed to show significant difference in ST resolution

The trial indicated that thrombectomy may not improve outcomes as expected.

19
Q

What was observed in patients who underwent thrombectomy in the AIMI trial?

A

Larger infarct size and higher 1-month MACE rate

MACE stands for major adverse cardiac events.

20
Q

What does the BOOST trial focus on?

A

Intracoronary autologous bone-marrow cell transfer after myocardial infarction

BOOST trial did not test thrombus aspiration.

21
Q

Fill in the blank: The TAPAS trial has been described _______.

A

[previously or elsewhere]

The specific details of the TAPAS trial were not included in the provided text.